Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 499,246 shares at $56.21 ($28.7M) on 2026-08-05, disclosed to the SEC on 2026-08-07.
Scheduled sale ($28.7M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.21 | 147,473 | $8.3M | 28.9% |
| 2 | $56.96 | 124,838 | $7.1M | 24.8% |
| 3 | $58.12 | 39,891 | $2.3M | 8.1% |
| 4 | $58.79 | 187,044 | $11.0M | 38.3% |
| Total | $57.52 avg | 499,246 | $28.7M | 100% |
| Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |
| MRNA | SELL | 2023-06-16 | $20.4M | — | Filing → |